Abstract
The frequent use of radiotherapy for abdominal and pelvic malignancies results in an increased risk of radiation enteritis. An increased understanding of the tissue response and the clinical features of radiation enteritis has led to advances in the prevention and management of this condition. Importantly, improvements in the delivery of radiotherapy, including techniques to reduce the amount of exposed small intestine in the radiation field, represent a critical strategy for prevention. Data indicate that radioprotectant agents have the potential to reduce intestinal mucosal injury and may be beneficial in reducing both acute and chronic side effects of radiotherapy.
Similar content being viewed by others
References and Recommended Reading
Alpen EL, ed.: Radiation Biophysics. Englewood Cliffs, NJ: Prentice-Hall; 1990.
Painter RB: The role of DNA damage and repair in cell killing by ionizing radiation. In Radiation Biology in Cancer Research. Edited by Meyer RE, Withers HR. New York: Raven Press; 1980:59–68.
Anderson RE: Radiation injury. In Anderson’s Pathology. Edited by Kissane JM. St. Louis: CV Mosby; 1985:239-277.
Sher ME, Bauer J: Radiation induced enteropathy. Am J Gastroenterol 1990, 85:121–128.
Sinclair WK: Cell cycle dependence on the lethal radiation response in mammalian cells. Curr Top Radiat Res Q 1972, 1:264–284.
Richter MP, Horvick D: Principles of radiation oncology. In Medical Oncology. Edited by Calabresi P, Schein PS. New York: McGraw-Hill; 1993:253–262.
Roswit B: Complications of radiation therapy: the alimentary tract. Semin Roentgenol 1974, 9:51–63.
Hasleton PS, Carr N, Schofield PF: Vascular changes in radiation bowel disease. Histopathology 1985, 9:517–534.
Hanson WR: Treatment of irradiated intestine with stem cell reconstitution techniques. In Radiation and the Gastrointestinal Tract. Edited by Dubois A, King GL, Livengood D. Boca Raton, FL: CRC Press; 1994:171–182.
Husebye E, Skar V, Hoverstad T, et al.: Abnormal intestinal motility pattern explains enteric colonization with gram-negative bacilli in late radiation enteropathy. Gastroenterology 1995, 109:1078–1089.
Perino LE, Schuffler MD, Mehta SJ, et al.: Radiation-induced intestinal pseudo-obstruction. Gastroenterology 1986, 91:994–998.
Canman CE, Kastan MB: Induction of apoptosis by tumor suppressor genes and oncogenes. Semin Cancer Biol 1995, 6:17–25.
Holahan EV Jr: Cellular radiation biology. In Military Radiobiology. Edited by Conklin JJ, Walker RI. New York: Academic Press; 1987:87–110.
Kinsella TJ, Bloomer WD: Tolerance of the intestine to radiation therapy. Surg Gynecol Obstet 1980, 151:273–284.
Weiss JF, Landauer MR, Gunter-Smith PJ, et al.: Effect of radioprotective agents on survival after acute intestinal radiation injury. In Radiation and the Gastrointestinal Tract. Edited by Dubois A, King GL, Livengood D. Boca Raton, FL: CRC Press; 1994:183–200.
Mitchell EP, Reynolds RD, Graden D, et al.: Chemotherapy and radiation protection with amifostine: clinical studies. In Radiation and the Gastrointestinal Tract. Edited by Dubois A, King GL, Livengood D. Boca Raton, FL: CRC Press; 1994:215–236.
Potish RA: Importance of predisposing factors in the development of enteric damage. Am J Clin Oncol 1982, 5:189–194.
Tarpila S: Morphological and functional response of human small intestine to ionizing radiation. Scand J Gastroenterol 1971, 6:1–52.
Summers RW, Flatt AJ, Prihoda M, et al.: Effect of irradiation on morphology and motility of canine small intestine. Dig Dis Sci 1987, 32:1402–1410.
Carpenter DO, Briggs DB, Knox AP, et al.: Radiation-induced emesis in the dog: effects of lesions and drugs. Radiat Res 1986, 108:307–316.
Otterson MF, Sarna SK, Moulder JE: Effects of fractionated doses of ionizing radiation on small intestinal motor activity. Gastroenterology 1988, 95:1249–1257.
Otterson MF, Sarna SK, Leming SC, et al.: Effects of fractionated doses of radiation on colonic motor activity. Am J Physiol 1992, 263:G518.
Stryker JA, Mortel R, Hepner GW: The effect of pelvic irradiation and ileal function. Radiology 1977, 124:213–216.
Alpers DH, Seetharam B: Pathophysiology of diseases involving intestinal brush border proteins. N Engl J Med 1977, 296:1047–1050.
Greenberger NJ, Isselbacher KJ: Malabsorption following radiation injury to the gastrointestinal tract. Am J Med 1964, 36:450–456.
Wellwood JM, Jackson BT: The intestinal complications of radiotherapy. Br J Surg 1973, 60:814–818.
Babb RR: Radiation proctitis: a review. Am J Gastroenterol 1996, 91:1309–1311.
Danielsson A, Nhylin H, Persson H, et al.: Chronic diarrhea after radiotherapy for gynaecological cancer: occurrence and etiology. Gut 1991, 32:1180–1187.
Yeoh E, Horowitz M, Russo A, et al.: Effect of pelvic irradiation on gastrointestinal function: a prospective longitudinal study. Am J Med 1993, 95:397–406.
Allen-Mersh TG, Wilson EJ, Hope-Stone HF, et al.: The management of late radiation-induced rectal injury after treatment of carcinoma of the uterus. Surg Gynecol Obstet 1987, 164:521–524.
Dietel M, To TB: Major intestinal complications of radiotherapy management and nutrition. Arch Surg 1987, 122:1421–1424.
Hauer-Jensen M: Late radiation injury of the small intestine: clinical, pathophysiologic and radiobiologic aspects. Acta Oncol 1990, 29:401–415.
Mann WJ: Surgical management of radiation enteropathy. Surg Clin North Am 1991, 71:977–990.
Heusinkveld RS, Manning MR, Aristizabal SA: Control of radiation-induced diarrhea with cholestyramine. Int J Radiat Oncol Biol Phys 1978, 4:687–690.
Mennie AT, Dalley VM, Dinneen LC, et al.: Treatment of radiation induced gastrointestinal distress with acetylsalicylate. Lancet 1975, 1:942–943.
Kilic D, Ozenirler S, Egehan I, Dursun: Sulfasalazine decreases acute gastrointestinal complications due to pelvic radiotherapy. Ann Pharmacother 2001, 35:806–810. An important study showing reduction of radiation injury with sulfasalazine.
Saclarides TJ, Rohrer DA, Bhattacharyya AK, et al.: Effect of intraoperative radiation on the tensile strength of small bowel anastomses. Dis Colon Rectum 1992, 35:151–157.
Galland RB, Spencer J: The natural history of clinically established radiation enteritis. Lancet 1985, 1:1257–1258.
Harling H, Balslev I: Long term prognosis of patients with severe radiation enteritis. Am J Surg 1988, 155:517–519.
van Halteren HK, Gertzak E, Taal BG, et al.: Surgical intervention for complications caused by late radiation damage of the small bowel: a retrospective analysis. Eur J Surg Oncol 1993, 19:336–341.
Dietz DW, Remzi FH, Fazio VW: Stricturoplasty for obstructing small bowel lesions in diffuse radiation enteritis: successful outcome in five patients. Dis Colon Rectum 2001, 44:1772–1777. Successful outcome reported in small study.
McArdle AH, Reid EC, Laplante MP, et al.: Prophylaxis against radiation injury: the use of elemental diet prior to and during radiotherapy for invasive bladder cancer and in early postoperative feeding following radical cystectomy and ileal conduit. Arch Surg 1986, 121:879–885.
Beer WH, Fan A, Halstead CH: Clinical and nutritional implications of radiation enteritis. Am J Clin Nutr 1985, 41:85–91.
Loiudice TA, Lang J: Treatment of radiation enteritis: a comparison study. Am J Gastroenterol 1983, 78:481–487.
Scolapio JS, Ukleja A, Burnes JU, Kelly DG: Outcome of patients with radiation enteritis treated with home parenteral nutrition. Am J Gastroenterol 2002, 97:662–666.
Green N, Iba G, Smith W: Measures to minimize small intestine injury in the irradiated pelvis. Int J Radiat Oncol Biol Physics 1975, 35:1633–1640.
Das I, Lanciano R, Movasa B, et al.: Efficacy of a belly board device with CT-simulation in reducing small bowel volume within pelvic irradiation fields. Int J Radiat Oncol Biol Physics 1997, 39:67–76.
Ferguson CM: Use of omental pedicle grafts in abdominoperineal resection. Am Surg 1990, 56:310–312.
Rodier JF, Jancer JC, Rodier D, et al.: Prevention of radiation enteritis by an absorbable polyglycolic acid mesh sling: a 60 case multicenter study. Cancer 1991, 68:2545–2549.
Brizel DM, Wasserman TH, Strnad V, et al.: Final report or phase III randomized trial of amifostine as a radioprotectectant, in head and neck cancer. Int J Radiat Oncol Biol Physics 1999, 45:147–148. Final results from important study.
Kemp G, Rose P, Lurain J, et al.: Amifostine pretreatment for protction against cyclophosphamide-induced toxicities: results of a randomized trial in patients with ovarian cancer. J Clin Oncol 1996, 14:2101–2112.
Lindegaard J, Grau: Has the outlook improved for amifostine as a clinical radioprotector? Radiother Oncol 2000, 57:113–118. Amifostine should only be used in experimental protocols, according to this report.
Capizzi R, Oster W: Chemoprotective and radioprotective effects of amifostine: an update of clinical trials. Int J Hematol 2000, 72:425–435. Analysis of data from phase II studies.
Halberg FE, Larue SM, Rayner AA, et al.: Intraoperative radiotherapy with localized radioprotection: diminished duodenal toxicity with intraluminal WR2721. Int J Radiat Oncol Biol Physics 1991, 29:1241–1246.
Denekamp J, Stewart FA, Rojas A: Is the outlook grey for WR-2721 as a clinical radioprotector? Int J Radiat Oncol Biol Physics 1983, 9:595–598.
Grissby PW, Plipich MV, Parsons CL: Preliminary results of a phase I/II study of sodium pentosanpolysulfate in the treatment of chronic radiation-induced proctitis. Am J Clin Oncol 1990, 13:28.
Souba WW, Klimbers US, Copeland EM III: Glutamine nutrition in the management of radiation enteritis. J Parenter Enter Nutr 1990, 14:106S-108S.
Wu SG, Miyamoto T: Radioprotection of the intestinal crypts of mice by recombinant human interleukin-1 alpha. Radiat Res 1990, 123:112–115.
Henrikson R, Franzen L, Lithbrood B: Effect of sucralfate on acute and late bowel discomfort following radiotherapy of pelvic cancer. J Clin Oncol 1992, 10:969–975.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bismar, M.M., Sinicrope, F.A. Radiation enteritis. Curr Gastroenterol Rep 4, 361–365 (2002). https://doi.org/10.1007/s11894-002-0005-3
Issue Date:
DOI: https://doi.org/10.1007/s11894-002-0005-3